Sandimmun(®) (ciclosporin, Cyclosporin A) Past experience and present uses in autoimmune diseases.

  • E. Wiskott
  • Published 1993 in Ocular immunology and inflammation

Abstract

Sandimmun (cyclosporin) is the established therapy to prevent graft rejection of all transplanted organs. The drug is also effective in several autoimmune diseases. Uveitis was the first clinical indication tested with Sandimmun systematically in the early eighties. Its use has been widely accepted particularly for the treatment of Behçet uveitis. However… (More)
DOI: 10.3109/09273949309085017

4 Figures and Tables

Topics

  • Presentations referencing similar topics